Grey Wolf Animal Health Corp.
WOLF.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.96% | 5.15% | 6.51% | 5.87% | 8.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.96% | 5.15% | 6.51% | 5.87% | 8.20% |
| Cost of Revenue | 2.26% | 4.01% | 7.32% | 8.85% | 9.56% |
| Gross Profit | 5.63% | 6.27% | 5.73% | 3.08% | 6.88% |
| SG&A Expenses | 4.19% | 5.44% | 1.01% | -7.50% | -8.90% |
| Depreciation & Amortization | -3.92% | -7.96% | -5.89% | -4.02% | -11.61% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.77% | 4.02% | 3.89% | 0.65% | -0.13% |
| Operating Income | 20.81% | 20.71% | 61.22% | 658.88% | 671.95% |
| Income Before Tax | 25.57% | -76.14% | -74.01% | -70.17% | -28.06% |
| Income Tax Expenses | 38.04% | 672.80% | 272.32% | 172.37% | 160.87% |
| Earnings from Continuing Operations | 15.66% | -86.32% | -86.55% | -91.37% | -73.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.66% | -86.32% | -86.55% | -91.37% | -73.80% |
| EBIT | 20.81% | 20.71% | 61.22% | 658.88% | 671.95% |
| EBITDA | 16.96% | 12.28% | 28.56% | 83.89% | 158.21% |
| EPS Basic | 1.43% | -92.82% | -92.96% | -95.60% | -85.94% |
| Normalized Basic EPS | 18.52% | -86.78% | -85.46% | -83.29% | -57.37% |
| EPS Diluted | -17.91% | -93.00% | -93.14% | -95.80% | -85.58% |
| Normalized Diluted EPS | 18.52% | -86.78% | -85.46% | -83.29% | -57.37% |
| Average Basic Shares Outstanding | -2.74% | 11.70% | 31.49% | 59.80% | 103.64% |
| Average Diluted Shares Outstanding | -2.74% | 11.70% | 31.49% | 59.80% | 103.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |